Verde Servicos Internacionais S.A. Biomarin Pharmaceutical Inc Transaction History

Verde Servicos Internacionais S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 14, 2019	SELL	$80.14 - $106.07 $1.18 Million - $1.56 Million	-14,677 Closed	0 $0
Q3 2018 Oct 03, 2018	SELL	$93.92 - $105.72 $124,350 - $139,973	-1,324 Reduced 8.27%	14,677 $1.38 Million
Q2 2018 Jul 05, 2018	SELL	$76.01 - $99.03 $199,450 - $259,854	-2,624 Reduced 14.09%	16,001 $1.51 Million
Q1 2018 Apr 13, 2018	SELL	$77.67 - $92.63 $73,398 - $87,535	-945 Reduced 4.83%	18,625 $1.51 Million
Q4 2017 Jan 29, 2018	BUY	$80.76 - $95.13 $1.58 Million - $1.86 Million	19,570	19,570 $1.75 Million

624

183M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Verde Servicos Internacionais S.A., based on Form 13F filings with the SEC.

Stay updated on Verde Servicos Internacionais S.A. with notifications on news.